321 related articles for article (PubMed ID: 7525888)
1. Tumor invasion, proteolysis, and angiogenesis.
Thorgeirsson UP; Lindsay CK; Cottam DW; Gomez DE
J Neurooncol; 1994; 18(2):89-103. PubMed ID: 7525888
[TBL] [Abstract][Full Text] [Related]
2. The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis.
VanMeter TE; Rooprai HK; Kibble MM; Fillmore HL; Broaddus WC; Pilkington GJ
J Neurooncol; 2001 Jun; 53(2):213-35. PubMed ID: 11716072
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activators and matrix metalloproteinases in angiogenesis.
Mignatti P; Rifkin DB
Enzyme Protein; 1996; 49(1-3):117-37. PubMed ID: 8797002
[TBL] [Abstract][Full Text] [Related]
4. The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis.
Ray JM; Stetler-Stevenson WG
Eur Respir J; 1994 Nov; 7(11):2062-72. PubMed ID: 7533104
[TBL] [Abstract][Full Text] [Related]
5. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis.
Pepper MS
Arterioscler Thromb Vasc Biol; 2001 Jul; 21(7):1104-17. PubMed ID: 11451738
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases and tissue inhibitor of metalloproteinases: a review of their role in tumorigenesis and tissue invasion.
Khokha R; Denhardt DT
Invasion Metastasis; 1989; 9(6):391-405. PubMed ID: 2689386
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of AIDS-Kaposi's sarcoma cell induced endothelial cell invasion by TIMP-2 and a synthetic peptide from the metalloproteinase propeptide: implications for an anti-angiogenic therapy.
Benelli R; Adatia R; Ensoli B; Stetler-Stevenson WG; Santi L; Albini A
Oncol Res; 1994; 6(6):251-7. PubMed ID: 7532474
[TBL] [Abstract][Full Text] [Related]
8. Different roles for plasminogen activators and metalloproteinases in melanoma metastasis.
Mueller BM
Curr Top Microbiol Immunol; 1996; 213 ( Pt 1)():65-80. PubMed ID: 8814995
[TBL] [Abstract][Full Text] [Related]
9. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
de Bart AC; Quax PH; Löwik CW; Verheijen JH
J Bone Miner Res; 1995 Sep; 10(9):1374-84. PubMed ID: 7502710
[TBL] [Abstract][Full Text] [Related]
10. Secretion of matrix metalloproteinase-2 (72 kD gelatinase/type IV collagenase = gelatinase A) by malignant human glioma cell lines: implications for the growth and cellular invasion of the extracellular matrix.
Nakagawa T; Kubota T; Kabuto M; Fujimoto N; Okada Y
J Neurooncol; 1996 Apr; 28(1):13-24. PubMed ID: 8740587
[TBL] [Abstract][Full Text] [Related]
11. Bimodal relationship between invasion of the amniotic membrane and plasminogen activator activity.
Tsuboi R; Rifkin DB
Int J Cancer; 1990 Jul; 46(1):56-60. PubMed ID: 2142142
[TBL] [Abstract][Full Text] [Related]
12. Expression of tissue inhibitors of metalloproteinases: negative regulators of human glioblastoma invasion in vivo.
Mohanam S; Wang SW; Rayford A; Yamamoto M; Sawaya R; Nakajima M; Liotta LA; Nicolson GL; Stetler-Stevenson WG; Rao JS
Clin Exp Metastasis; 1995 Jan; 13(1):57-62. PubMed ID: 7820957
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
14. The role of tissue inhibitor of metalloproteinase-1 in specific aspects of cancer progression and reproduction.
Khokha R; Waterhouse P
J Neurooncol; 1994; 18(2):123-7. PubMed ID: 7525887
[TBL] [Abstract][Full Text] [Related]
15. Reverse transcription-polymerase chain reaction phenotyping of metalloproteinases and inhibitors involved in tumor matrix invasion.
Onisto M; Garbisa S; Caenazzo C; Freda MP; Di Francesco C; Nitti D; Liotta LA; Stetler-Stevenson WG
Diagn Mol Pathol; 1993 Jun; 2(2):74-80. PubMed ID: 8269280
[TBL] [Abstract][Full Text] [Related]
16. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y
J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952
[TBL] [Abstract][Full Text] [Related]
17. Characterization of matrix-degrading proteinases and their inhibitors secreted by human gynecological carcinoma cells.
Miyagi E; Yasumitsu H; Hirahara F; Minaguchi H; Koshikawa N; Miyazaki K; Umeda M
Jpn J Cancer Res; 1995 Jun; 86(6):568-76. PubMed ID: 7622422
[TBL] [Abstract][Full Text] [Related]
18. [Roles of serine proteases and matrix metalloproteinases in tumor invasion and angiogenesis].
Masson V
Bull Mem Acad R Med Belg; 2006; 161(5):320-6. PubMed ID: 17283905
[TBL] [Abstract][Full Text] [Related]
19. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum.
Hayakawa T; Yamashita K; Tanzawa K; Uchijima E; Iwata K
FEBS Lett; 1992 Feb; 298(1):29-32. PubMed ID: 1544418
[TBL] [Abstract][Full Text] [Related]
20. Cooperation between matrix metalloproteinases and the plasminogen activator-plasmin system in tumor progression.
DeClerck YA; Laug WE
Enzyme Protein; 1996; 49(1-3):72-84. PubMed ID: 8796998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
